Pfizer and Novo Nordisk intensify Metsera bidding war
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Biotechnology and pharmaceuticals
Pfizer (PFE) earnings in the third quarter of 2025
Albert Bourla, CEO of Pfizer, speaks during a press conference after a visit to oversee the production of the Pfizer-BioNtech…
Pfizer files second lawsuit against Novo Nordisk and Metsera
A Pfizer logo is displayed at a research center in the La Jolla neighborhood of San Diego, California, U.S., on…
Eli Lilly and Walmart to Offer Discounted Retail Option for Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Stocks of breast cancer drug Olema could more than double from now on, analysts say
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…
Merck (MRK) Earnings Q3 2025
merck On Thursday it reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its Keytruda…
This biotech stock is up almost 50% in 3 months. Its CEO says the business is “growing substantially”
It's been a stellar few months for the San Francisco-based biotech company's stock Rigel Pharmaceuticalswhich has approved treatments for hematology…
Eli Lilly (LLY) Earnings in Q3 2025
David Ricks, CEO of Eli Lilly & Co., during a press conference at Generation Park in Houston, Texas, U.S., Tuesday,…
FDA to speed up approval of generic drugs as Trump takes aim at drug costs
U.S. Food and Drug Administration Commissioner Marty Makary speaks during a news conference alongside U.S. Health and Human Services Secretary…
CVS Health (CVS) Third Quarter 2025 Earnings
Signage at a CVS pharmacy in Takoma Park, Maryland, USA, on Wednesday, July 9, 2025. To Drago | Bloomberg |…